OptimizeRx Corporation provides various solutions to life sciences organizations, healthcare providers, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies.
Market Cap | 325.73 Million | Shares Outstanding | 17.153 Million | Avg 30-day Volume | 139.064 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -0.02 |
Price to Revenue | 4.2226 | Debt to Equity | 0.0 | EBITDA | -8.555 Million |
Price to Book Value | 2.0566 | Operating Margin | -17.1218 | Enterprise Value | 187.683 Million |
Current Ratio | 16.193 | EPS Growth | -9.143 | Quick Ratio | 15.749 |
1 Yr BETA | 1.4092 | 52-week High/Low | 49.24 / 13.33 | Profit Margin | -16.6208 |
Operating Cash Flow Growth | 1324.7687 | Altman Z-Score | 25.9289 | Free Cash Flow to Firm | -16.577 Million |
Earnings Report | 2023-02-23 |
Please sign in first
none
none
11.7 Thousand total shares from 6 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
FEBBO WILLIAM J CEO |
|
481,028 | 2023-01-07 | 3 |
|
18,674 | 2022-12-30 | 4 | |
|
65,571 | 2022-12-30 | 4 | |
|
16,826 | 2022-12-30 | 4 | |
|
34,133 | 2022-12-30 | 6 | |
|
39,403 | 2022-12-30 | 5 | |
ODENCE-FORD MARION GENERAL COUNSEL AND CCO |
|
9,645 | 2022-11-08 | 5 |
SILVESTRO STEPHEN L CHIEF COMMERCIAL OFFICER |
|
59,002 | 2022-10-03 | 3 |
INMAN TODD CHIEF TECHNOLOGY OFFICER |
|
29,500 | 2022-10-03 | 2 |
STELMAKH EDWARD CFO/COO |
|
147,504 | 2022-10-03 | 2 |
BESCH DOUG CHIEF PRODUCT OFFICER |
|
29,500 | 2022-10-03 | 2 |
PARAMORE MIRIAM J PRESIDENT AND CSO |
|
165,367 | 2021-12-02 | 0 |
BAKER DOUGLAS P CHIEF FINANCIAL OFFICER |
|
69,495 | 2021-10-05 | 0 |
|
No longer subject to file | 2019-05-14 | 0 | |
HAMILTON TERRENCE SVP OF SALES |
|
141,471 | 2019-03-27 | 0 |
|
No longer subject to file | 2018-12-20 | 0 | |
|
0 | 2018-03-23 | 0 | |
|
812,329 | 2018-01-10 | 0 | |
|
2,090,750 | 2017-06-01 | 0 | |
DILLON BRIAN J SR. VP OF PRODUCT & STRATEGY |
|
0 | 2016-07-28 | 0 |
BROOKS JAMES M SVP OF BUSINESS DEVELOPMENT |
|
10,000 | 2016-06-08 | 0 |
|
No longer subject to file | 2014-07-24 | 0 | |
LESTER DAVID COO |
|
423,348 | 2014-05-01 | 0 |
|
1,362,250 | 2011-08-05 | 0 | |
|
0 | 2010-07-28 | 0 | |
|
222,750 | 2008-04-30 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-01-31 16:50:44 -0500 | 2023-01-07 | M | 9,628 | a | 471,400 | direct | 2.6483 | 2.6483 | 2 | 0.0 | 1 | |||||
2023-01-31 16:50:44 -0500 | 2023-01-07 | M | 9,628 | d | 9,628 | direct | ||||||||||
2023-01-04 16:04:03 -0500 | 2022-12-30 | M | 409 | a | 39,403 | direct | -3.8049 | -1.8221 | 1.5541 | 4 | -3.8049 | 2 | ||||
2023-01-04 16:04:03 -0500 | 2022-12-30 | M | 409 | d | 0 | direct | ||||||||||
2023-01-04 16:04:56 -0500 | 2022-12-30 | M | 409 | a | 16,826 | direct | -3.8049 | -1.8221 | 1.5541 | 4 | -3.8049 | 2 | ||||
2023-01-04 16:04:56 -0500 | 2022-12-30 | M | 409 | d | 0 | direct | ||||||||||
2023-01-04 16:06:26 -0500 | 2022-12-30 | M | 409 | a | 34,133 | direct | -3.8049 | -1.8221 | 1.5541 | 4 | -3.8049 | 2 | ||||
2023-01-04 16:06:26 -0500 | 2022-12-30 | M | 409 | d | 0 | direct | ||||||||||
2023-01-04 16:07:52 -0500 | 2022-12-30 | M | 409 | a | 18,674 | direct | -3.8049 | -1.8221 | 1.5541 | 4 | -3.8049 | 2 | ||||
2023-01-04 16:07:52 -0500 | 2022-12-30 | M | 409 | d | 0 | direct | ||||||||||
2023-01-04 16:10:12 -0500 | 2022-12-30 | M | 409 | a | 65,571 | direct | -3.8049 | -1.8221 | 1.5541 | 4 | -3.8049 | 2 | ||||
2023-01-04 16:10:12 -0500 | 2022-12-30 | M | 409 | d | 0 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
OPTIMIZERX CORP OPRX | 2023-02-03 22:15:03 UTC | 4.1619 | 0.4081 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 21:45:03 UTC | 4.1619 | 0.4081 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 21:15:03 UTC | 4.1619 | 0.4081 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 20:45:06 UTC | 4.1619 | 0.4081 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 20:15:04 UTC | 4.1619 | 0.4081 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 19:45:03 UTC | 4.1619 | 0.4081 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 19:15:04 UTC | 4.1619 | 0.4081 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 18:45:03 UTC | 4.0922 | 0.4778 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 18:15:03 UTC | 4.0922 | 0.4778 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 17:45:03 UTC | 4.0922 | 0.4778 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 17:15:04 UTC | 4.0922 | 0.4778 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 16:45:04 UTC | 4.0922 | 0.4778 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 16:15:03 UTC | 4.0922 | 0.4778 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 15:45:03 UTC | 4.2826 | 0.2874 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 15:15:03 UTC | 4.2826 | 0.2874 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 14:45:04 UTC | 4.0493 | 0.2707 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 14:15:04 UTC | 4.0493 | 0.2707 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 13:45:03 UTC | 4.0493 | 0.2707 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 13:15:03 UTC | 4.0493 | 0.2707 | 200000 |
OPTIMIZERX CORP OPRX | 2023-02-03 12:45:03 UTC | 4.0493 | 0.2707 | 200000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund | OPRX | -1832.0 shares, $-27150.24 | 2022-09-30 | N-PORT |
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund | OPRX | -9981.0 shares, $-153857.12 | 2022-10-31 | N-PORT |